RecruitingNot ApplicableNCT06250712

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

Sponsor

Wonju Severance Christian Hospital

Enrollment

588 participants

Start Date

Feb 22, 2024

Study Type

INTERVENTIONAL

Conditions

Arrhythmia

Summary

The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Continous ECG Patch and a medical device called Intermittent handheld ECG for people with arrhythmia. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.